Authors:
ELLINGBOE JW
COLLINI MD
QUAGLIATO D
CHEN J
ANTANE M
SCHMID J
HARTUPEE D
WHITE V
PARK CH
TANIKELLA T
BAGLI JF
Citation: Jw. Ellingboe et al., METABOLITES OF THE ANGIOTENSIN-II ANTAGONIST TASOSARTAN - THE IMPORTANCE OF A 2ND ACIDIC GROUP, Journal of medicinal chemistry, 41(22), 1998, pp. 4251-4260
Citation: La. Ochalski et al., ROLE OF ANGIOTENSIN-II AT1 RECEPTORS IN REGIONAL HEMODYNAMICS IN CONSCIOUS GOLDBLATT (2K-1C) HYPERTENSIVE RATS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1453-1453
Authors:
PARK CH
ELLINGBOE J
COLLINI M
NGUYEN T
BAGLI J
RUSSO A
HARTUPEE D
OSHIRO G
COLATSKY TJ
Citation: Ch. Park et al., WAY-ANA-756, A NEW AT1-SELECTIVE NONPEPTIDIC ANGIOTENSIN-II (AII) RECEPTOR ANTAGONIST, The FASEB journal, 8(4), 1994, pp. 10000005-10000005
Authors:
HARTUPEE D
WHITE V
ROVNYAK L
MCCALLUM J
METZ N
WOJDAN A
DINISH J
PARK CH
OSHIRO G
ELLINGBOE J
NGUYEN T
COLLINI M
BAGLI J
COLATSKY T
Citation: D. Hartupee et al., IN-VIVO CHARACTERIZATION OF WAY-ANA-756, AN ANGIOTENSIN-II (AII) ANTAGONIST, The FASEB journal, 8(4), 1994, pp. 10000005-10000005
Authors:
ELLINGBOE JW
ANTANE M
NGUYEN TT
COLLINI MD
ANTANE S
BENDER R
HARTUPEE D
WHITE V
MCCALLUM J
PARK CH
RUSSO A
OSLER MB
WOJDAN A
DINISH J
HO DM
BAGLI JF
Citation: Jw. Ellingboe et al., PYRIDO[2,3-D]PYRIMIDINE ANGIOTENSIN-II ANTAGONISTS, Journal of medicinal chemistry, 37(4), 1994, pp. 542-550